![]() |
|
|


* Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 462025122 and
Division of Nutritional Sciences, Department of Animal Sciences and
** Department of Food Science and Human Nutrition, University of Illinois, Urbana, IL 61801
| ABSTRACT |
|---|
|
|
|---|
-ketoacid dehydrogenase
(BCKDH) complex, affects the activity state of the complex. Rats were
fed a chemically-defined diet containing graded levels of thiamin (0,
0.275, 0.55, 5.5, and 55 mg thiamin/kg diet). Maximal weight gain was
attained over a 3-wk period only in rats fed diets with 5.5 and 55 mg
thiamin/kg. Feeding rats the thiamin-free diet for just 2 d caused
loss of nearly half of the TDP from liver mitochondria. Three more days
caused over 70% loss, an additional 3 wk, over 90%. Starvation for
2 d had no effect, suggesting a mechanism for conservation of TDP
in this nutritional state. Mitochondrial TDP was higher in rats fed
pharmacological amounts of thiamin (55 mg thiamin/kg diet) than in rats
fed adequate thiamin for maximal growth. Varying dietary thiamin had
marked but opposite effects on the activities of
-ketoglutarate
dehydrogenase (
-KGDH) and BCKDH. Thiamin deficiency decreased
-KGDH activity, increased BCKDH activity, and increased the
proportion of BCKDH in the active, dephosphorylated, state. Excess
dietary thiamin had the opposite effects. TDP appears to be more
tightly associated with
-KGDH than BCKDH in thiamin-deficient rats,
perhaps denoting retention of
-KGDH activity at the expense of BCKDH
activity. Thus, thiamin deficiency and excess cause large changes in
mitochondrial TDP levels that have a major influence on the activities
of the keto acid dehydrogenase complexes.
KEY WORDS: rats thiamin liver mitochondria thiamin-dependent enzymes
| INTRODUCTION |
|---|
|
|
|---|
-ketoglutarate dehydrogenase (
-KGDH), and
branched-chain
-ketoacid dehydrogenase (BCKDH). Thiamin is
transported across cell membranes by three mechanismstwo saturable
components that are responsive to low and high physiological
concentrations of thiamin (Bettendorff 1995
The first sign of thiamin deficiency is the depletion of tissue thiamin
stores, of which TDP comprises over 80% (Rindi & de Giuseppe
1961
). Before enzymic activity in those reactions that require
TDP as a cofactor is curtailed, thiamin is drastically depleted
(Warnock et al. 1978
). There is a rapid decrease in
total TDP in rat tissues after only 10 d of feeding a
thiamin-deficient diet. Depletion of TDP is greatest and fastest in the
liver, followed by the heart, with only a minimal drop occurring in the
brain (Dreyfuss 1961
). It is probable that, in addition
to adequate, though not excessive, levels of essential nutrients and
energy components in the sustaining diet, the nutritional state of
animals (or patients) before initiation of thiamin treatment, is a key
factor in the determination of deficiency characteristics (Baker 1986
).
The mechanism by which pharmacological thiamin doses exert a beneficial
effect on MSUD patients is not understood. In the current report we
have addressed this problem by using graded levels of thiamin,
including a pharmacological level of 55 mg/kg diet, blended into a
chemically defined diet to evaluate thiamin status in reference to the
activity of the BCKDH complex. In a recent publication (Rains et al. 1997
), a chemically defined diet for weanling rats was used
to specify the minimum thiamin requirement to promote maximal weight
gain over 3 wk. This diet easily accommodated the addition of graded
levels of thiamin and was used as the basal diet for studying thiamin
deficiency and a pharmacological level of dietary thiamin.
| MATERIALS AND METHODS |
|---|
|
|
|---|
All animal regimens were in accordance with Indiana University School
of Medicine animal care recommendations. Male Sprague-Dawley rats
(Harlan, Indianapolis, IN) weighing 95 ± 10 g were confined
individually in stainless steel (wire mesh bottom) cages in a
controlled (23°C; 12 h light and dark cycle) environment. Each
replication commenced with nine rats randomly assigned to treatments.
Four replications were conducted over a period of 5 wk. Rat 1 received
no treatment and was killed at Time zero. Rats 2 and 3 were fed a
non-purified diet(Teklad Rodent Diet (W) No. 8604; Harlan Industries,
Indianapolis, IN)one for 5 d before being killed, the other for
26 d before being killed. Rats 49 were acclimated for 5 d
on a thiamin-free chemically-defined diet. One was then killed and the
remaining five were fed the chemically-defined diet (Rains et al. 1997
) with thiamin added at a level of 0, 0.275, 0.55, 5.5,
or 55 mg thiamin/kg diet. Water was freely available, and droppings
through the wire bottom were washed away routinely. Weights of rats
were measured before acclimation started (Time zero); upon completion
of acclimation (5 d); and twice each week for 3 wk, with the last
weight taken just before they were killed.
In the experiment that tested the effects of 5 d acclimation to the thiamin-free chemically-defined diet, four individually caged rats were fed the defined diet and four were fed the non-purified reference diet. After weighing, rats were killed at the end of 5 d.
To compare the results of starvation to the results of feeding the thiamin-free chemically-defined and non-purified reference diets, 35 rats, individually caged and weighed, were placed in each group. The starved and non-purified reference diet-fed rats were 3 d older than those fed the thiamin-free diet. After 48 h of treatment, the rats were weighed and killed. All rats were fed the reference diet before starvation or dietary treatments were started.
Animals were killed with a guillotine. Blood (13 mL) was collected in 30 mL beakers lined with heparin, then immediately chilled to 0°C in an ice bath. The blood was transferred to 1.5 mL tubes for centrifugation at ~11,000 x g in an Eppendorf microcentrifuge for 2 min. The supernatant fluid (plasma) was decanted into new tubes. Both plasma and cells were quickly frozen at -85°C.
When bleeding was over, the abdominal cavity of each rat was opened and the liver excised. Approximately 1/2 of each liver was quickly frozen in a clamping device immersed in liquid nitrogen just before and after clamping the liver sample. After freezing, the liver half was weighed and then stored at -85°C. The remaining liver half was weighed before placing in chilled (0°C) mitochondrial isolation medium (~30 mL).
Isolation of liver mitochondria.
The chilled livers were rinsed twice with 250 mmol sucrose/L -1 mmol
EGTA/L (0°C, pH 7.4) before mincing with scissors (30 s). Before
homogenizing and centrifuging by a described procedure (Blair 1977
), the volume was brought to ~40 mL. A 1-mL sample of the
homogenate was withdrawn and quickly frozen (-85°C). The final
mitochondrial pellet was suspended in a small volume of sucrose-EGTA.
Protein concentrations of blood plasma, liver homogenates, and liver
mitochondria were estimated by a biuret method (Gornall et al. 1949
) modified to treat the peculiarity of each sample after
solubilization with sodium deoxycholate. For example, liver homogenate
samples were routinely centrifuged after solubilization and heating
(100°C for 20 s) to insure turbidity did not interfere with the
specific spectrophotometric reading. Crystalline bovine serum albumin
served as the protein standard. After determining oxygen consumption
rates stimulated by rat liver mitochondria (RLM), the RLM were frozen
(-85°C). All samples were stored at -85°C until the measurable
parameters were completed.
Mitchondrial oxygen consumption.
Rat liver mitochondria were added to an isoosmotic reaction solution in
a 2 mL water-jacketed cell of a Gilson Oxygraph maintained at 30°C.
Oxidizable substrates used were succinate (plus rotenone) and glutamate
(plus malate) each at 10 mmol/L. The addition of 1 mg of RLM protein
started state-2 respiration (Chance and Williams 1955
).
State-3 respiration was initiated with 600 nmol of adenosine
diphosphate (ADP). When ADP-stimulated respiration decreased to
approximately the same rate as that seen in state-2, it was assumed the
added ADP was consumed [converted to adenosine triphosphate (ATP)],
which in turn was the start of state-4 respiration. The respiratory
control ratio (state-3 respiration rate ÷ state-4 respiration
rate) was used to evaluate RLM integrity.
Thiamin determinations.
Total thiamin, corresponding primarily to TDP, with much lesser amounts
of thiamin, thiamin monophosphate, and thiamin triphosphate was
determined by a fluorescence assay (Edwin 1979
) modified
to suit our particular experiments. Samples of blood plasma, liver
homogenate, or liver mitochondria (1 mg protein in 1 mL) were extracted
with HCl acid, and the precipitate was removed by centrifugation in an
Eppendorf microcentrifuge (1.5 mL tube, 2 min). The supernatant fluid
(1 mL) was neutralized with NaOH prior to diluting in an
alcoholic-aqueous solution. The reduced fluorescence spectrum of the
solution was run from 390 nm to 490 nm in a Varian (Palo Alto, CA)
SF-330 Spectrofluorometer with the excitation wavelength set at 368 nm.
The reduced form of thiamin has little or no fluorescence. The thiamin
and thiamin phosphates (total thiamin) in solution were oxidized to
thiochrome with K3Fe(CN)6. After thiochrome
formation, the hydrophobic thiamin can be separated from the thiamin
phosphates by extraction into isobutanol. The phosphate derivatives
remain in the alcoholic-aqueous phase. The ferricyanide color must be
cleared with H2O2 before the oxidized spectrum
can be run. The thiochrome is highly fluorescent. Total thiamin
concentration is estimated by the difference in fluorescence of the
reduced versus the oxidized form at peak fluorescence, which is about
430 nm. Concentrations were obtained by comparison to standard
concentrations of purified thiamin treated and scanned in the same
manner. The fluorescence was linear within reasonable limits, at least
over the levels of thiamin used in our assays. Thiamin and the thiamin
phosphates yield the same quantity of fluorescence under the conditions
of our assay.
Activity of enzymes.
Cell-free extracts for the assay of liver BCKDH and
-KGDH were
prepared essentially as described in previous reports (Aftring et al. 1986
, Shimomura et al. 1990
). Briefly,
one portion of frozen liver was powdered in liquid nitrogen, weighed,
and homogenized in an extraction buffer (Shimomura et al. 1990
) containing Triton-X100, protease inhibitors,
-chloroisocaproate (BCKDH kinase inhibitor), potassium fluoride
(BCKDH phosphatase inhibitor), and TDP (0.5 mmol/L). A second portion
of the liver was homogenized with this same extraction buffer, except
that TDP was omitted. Insoluble material was removed from both extracts
by centrifugation. Polyethylene glycol (final concentration 9%) was
then added to the supernatant fluid to precipitate the BCKDH and
-KGDH complexes. The polyethylene glycol precipitates from the
extracts prepared with TDP were taken up in a suspending buffer
containing 0.5 mmol TDP/L, as described previously (Shimomura et al. 1990
). The precipitates prepared without TDP were taken up
in the same suspending buffer without TDP.
The extracted BCKDH and
-KGDH complexes were assayed
spectrophotometrically in a cocktail (Paxton et al 1986
,
Shimomura et al. 1987
) with
-ketoisovalerate and
-ketoglutarate as substrates, respectively. The assays were carried
out with and without TDP (0.5 mmol/L) in the assay cocktail. One unit
of enzyme activity catalyzed the reduction of 1 µmol of
NAD+/min at 30°C.
Statistical analysis.
ANOVA (using a multiple crossed classification procedure with body weight, pmol thiamin/mg protein, and mU enzymatic activity/g wet liver as measured variables) was applied to all data, and single degree-of-freedom comparisons were made among treatment means for each diet and measured variable.
| RESULTS |
|---|
|
|
|---|
Rats fed the thiamin-free purified diet for 5 d (acclimation
period) gained about the same amount of weight as those fed the
non-purified reference diet (Table 1)
. During the 21-d period of feeding the experimental diet, body weights
responded to thiamin dosing, particularly after 7 d of feeding. In
fact, between d 7 and 21, rats fed either 0 or 0.275 mg thiamin/kg diet
lost weight. Weight change at Day 21 of the feeding period increased as
a function of dietary thiamin level between 0 and 5.5 mg thiamin/kg
diet (P < 0.05). Dietary thiamin levels of 5.5 and 55
mg/kg produced weight gains that did not differ (P >
0.10), and the weight gains of rats fed these diets were not different
(P > 0.10) from those of rats fed the non-purified
reference diet containing 10.8 mg thiamin/kg diet. Changes in liver
weight paralleled the changes in body weight, although liver weight as
a percentage of body weight was lower (P < 0.05) in
rats receiving thiamin-deficient diets (0.0 to 0.55 mg thiamin/kg diet,
respectively) compared to those fed diets containing 5.5 or 55 mg
thiamin/kg diet (data not shown).
|
|
|
The quality of the mitochondria isolated from the livers of all rats
was good, as judged by oxygen consumption studies. The respiratory
control ratio (state-3 respiration ÷ state-4 respiration) was in most
cases >5, using succinate as oxidizable substrate. The ratio was
invariably higher when glutamate was used as a substrate. Glutamate
(source of
-ketoglutarate) oxidation rates of RLM were not affected
by dietary thiamin concentration (data not shown).
Effects of graded levels of dietary thiamin on activity and activity state of the BCKDH complex.
To determine the actual activity of the enzyme, BCKDH activity was
measured before activation with a phosphatase, and to give the maximum
total activity, after activation with a phosphatase (Table 4)
. The first response of BCKDH to thiamin deficiency was a lowering of
activity as seen after 5 d of acclimation to the thiamin-free diet
(Table 4)
. However, in rats fed a thiamin-deficient diet during the
following 21 d, BCKDH activity was restored and actually exceeded
the activity found in rats fed >0.55 mg thiamin/kg diet. The livers of
rats fed chemically-defined diets containing 0 and 0.275 mg thiamin/kg
diet had BCKDH activities that were double (P < 0.05)
those of rats fed 5.5 or 55 mg thiamin/kg diet, in spite of having only
10% of the total thiamin content (Table 2)
. A greater (P
< 0.05) proportion of BCKDH was in the active (nonphosphorylated)
form in rats fed 0 and 0.275 mg thiamin/kg diet versus rats fed 5.5 and
55 mg thiamin/kg diet (65 vs. 33%). In rats fed a 0.55 mg thiamin/kg
diet there was an intermediate level of total activity, even though the
active form was less prevalent than in rats fed the lower thiamin
levels (26 vs. 65%). As expected from previous work (Gillim et al. 1983
, Harris et al. 1985
), the BCKDH was
mostly in the active (nonphosphorylated) form in rats fed the
non-purified reference diet. A lower activity state of the complex was
expected in the rats fed the purified diet because of its lower protein
(amino acid) concentration (16 vs. 24 g/100 g for the non-purified
reference diet).
|
-KGDH complex activities.
BCKDH and
-KGDH complex activities were measured in liver extracts
prepared and assayed in the presence and absence of TDP (Table 5)
. The portion of the enzyme activity that was latent, i.e. the portion
requiring exogenous TDP (apoenzyme) for expression of activity, was
then calculated as previously described by Pekovich et al. (1996)
. As expected, the activity of BCKDH was lower
(P < 0.05) in the absence (apoenzyme) than in the
presence of added TDP (holoenzyme), when rats were fed either the
chemically-defined diet or the non-purified reference diet. However,
the proportion of liver holoenzyme was much less in rats fed the
chemically-defined diet (1031%) than in rats fed the non-purified
reference diet (>50%), even though the TDP level in liver
mitochondria of the rats fed the chemically-defined diet with high
thiamin was comparable to that of rats fed the non-purified reference
diet.
|
The activity of the liver
-KGDH complex of rats fed
thiamin-deficient diets (0, 0.275, and 0.55 mg thiamin/kg diet) was
lower (P < 0.05) than in rats fed diets containing 5.5
mg thiamin/kg diet (Table 5)
. When the
-KGDH complex was extracted
and assayed without added TDP, a substantial amount of activity was
found in livers of thiamin-deficient rats. When dietary thiamin
exceeded the National Research Council recommended level, almost all of
the
-KGDH activity was manifested without adding TDP.
Additional evidence for firm binding of TDP to the
-KGDH was seen
during the adjustment to the chemically-defined diet. The 5 d of
acclimation to the chemically-defined thiamin-free diet decreased the
liver thiamin from ~200 pmol/mg protein to 60 pmol/mg protein (Table 2)
, but the
-KGDH remained 90% saturated with TDP when it was
extracted and assayed without adding TDP (1,230 mU/g wet liver compared
to 1,111 mU/g).
During the 5 d of acclimation to the chemically-defined
thiamin-free diet the livers of rats lost 70% of their thiamin (Table 2)
, 30% of their total BCKDH activity (Table 4)
, and 40% of their
-KGDH activity (Table 5)
. The amount of nonphosphorylated (active)
BCKDH was 23%, and the amount of BCKDH with TDP bound was 5%, whereas
the amount of
-KGDH with TDP bound was 90%. This clearly signifies
that TDP is more firmly bound to
-KGDH than to BCKDH, and
-KGDH
activity is preferentially conserved when TDP becomes limiting in
mitochondria.
Only when dietary thiamin is severely limiting (0 mg thiamin/kg diet)
for 26 d does liver
-KGDH lose most (89%) of its activity
(Table 5)
, but high latent activity, or apoenzyme, (requires added TDP)
remains. In rats fed the other two deficient diets (0.275 and 0.55
mg/kg) more activity (holoenzyme) was retained, with a loss in latency
or apoenzyme (Table 5)
. In rats fed adequate dietary thiamin (5.5 or 55
mg/kg), almost full
-KGDH activity (over 90%) was manifested
without added TDP. Although the liver BCKDH of rats fed the
thiamin-free diet retained ~12% of its total activity, additional
thiamin in the diet (5.5 mg/kg) did not restore latent activity. In
fact, even with high thiamin in the purified diet (55 mg/kg) and in the
liver (233 pmol/mg protein), 69% of the BCKDH was inactive
(phosphorylated) or latent (needed added TDP).
| DISCUSSION |
|---|
|
|
|---|
The protocol used by Rains et al. (1997)
involved a 5-d
pretest period, during which time 5 mg thiamin/kg diet was fed. In the
subsequent 21 d, graded doses of thiamin were fed and weight gain
and efficiency of diet utilization were maximized at a dietary thiamin
level of 0.55 mg/kg. The data herein together with the study of
Mercer et al. (1986)
involved thiamin dose-titration
using rats that had been depleted or reduced in thiamin stores (Table 2)
. It appears clear from both our study and the earlier study of
Mercer et al. (1986)
that 0.55 mg thiamin/kg diet is
inadequate to maximize weight gain and maintain thiamin (mainly TDP)
stores in the liver of thiamin-depleted weanling rats.
Our data herein indicated that weight gains were considerably greater
for rats fed 5.5 mg thiamin/kg diet than for those fed 0.55 mg/kg.
Thus, the minimal thiamin requirement for maximal weight gain of
thiamin-deprived weanling rats probably lies between 0.55 and 5.5 mg
thiamin/kg diet. The surfeit level (55 mg thiamin/kg diet) of thiamin
tested resulted in (liver) total thiamin levels in the tissues that
were significantly greater (P < 0.05) than those of
rats fed 5.5 mg/kg. We do not consider this grounds for suggesting that
the dietary thiamin requirement exceeds 5.5 mg/kg. Maximal tissue
stores of thiamin may be beneficial for patients with MSUD, but our
data indicate it is unlikely that they are necessary for normal animals
(or humans). This result may help in understanding the relief of
symptoms of the MSUD syndrome in certain patients termed
thiamin-responsive (Elsas and Danner 1982
,
Fernhoff et al. 1985
, >Scriver et al. 1981
and
1985
).
Although thiamin-responsive MSUD patients result from a mutation in the
DNA that is the template for the E2 (acyl transferase) subunit of BCKDH
(Danner et al. 1985
, Fisher et al. 1991
,
Herring et al. 1992
), the BCAA levels in blood are
decreased by thiamin inclusion in the nutrient supply. Such MSUD
patients may have as little as 3% of normal BCKDH activity, and
maximal response to thiamin therapy may require 3 wk. Perhaps this is
an indication of long-term thiamin-inducted expression of mutated BCKDH
or its component proteins in compensation for the very low catalytic
activity of the altered enzyme complex, though this induction of
expression is not strongly supported by our data on the activity of the
nonmutated BCKDH in liver of thiamin-deficient rats.
It is interesting that the thiamin concentration was not reduced in plasma, liver, or liver mitochondria of rats during starvation for 2 d. In fact, thiamin in liver homogenates was actually increased, perhaps because of a reduction in liver size (nearly 50%) with retention of intracellular thiamin phosphates. In contrast, rats fed the thiamin-free diet for only 2 d had a liver thiamin concentration ~30% of normal and a mitochondrial level ~50% of normal, while body weight gains were normal. Part of the difference in liver thiamin levels can be explained by a need for less thiamin as the body loses mass during starvation versus a need for more thiamin as the body continues to grow while fed a thiamin-free diet. The data also suggest, however, that food deprivation signals the liver of rats to restrict the loss of essential nutrients, such as thiamin.
The normal level of thiamin in the plasma of rats is 4050 pmol/mg
protein. In 5 d, the acclimation period, this level was reduced in
rats fed the thiamin-free diet to virtually the minimal concentration
(20 to 30 pmol/mg protein). Moreover, plasma thiamin remained at this
level for the next 21 d when dietary thiamin levels < 0.55 mg/kg
were fed. It takes a few days longer to minimize the liver thiamin, and
it was never truly minimized during the 21-d trial in rats fed the 0.55
mg thiamin/kg diet. When the chemically-defined diet contained 5.5 mg
thiamin/kg diet, tissue thiamins were replenished and supported maximal
weight gain rates even though the plasma and liver concentrations were
not yet maximized. This observation is in partial agreement with the
study by Mercer et al. (1986)
on the thiamin requirement
for thiamin-depleted rats, which concluded that the minimal thiamin
requirement for optimal growth should be 4.0 mg thiamin
hydrochloride/kg diet.
Rats fed thiamin-deficient diets (with only 2.8% BCAA) had double the
liver BCKDH activity of rats fed the same diet containing adequate (5.5
mg/kg) or excess thiamin (Table 4)
. Almost all of the activity was
latent (in the apoenzyme form or phosphorylated), requiring both TDP
and dephosphorylation of the enzyme complex to recover full activity.
The enhanced activity in livers of thiamin-deficient rats was not
caused by increased BCAA in the blood plasma. Amino acid analysis
revealed that BCAA in the plasma (108125 µmol/L) were not different
in rats fed the varying levels of thiamin in the chemically-defined
diet (Blair, Liechty, & Harris, unpublished observations). The increase
in BCKDH activity may be an induction response to the presence of BCAA
(though not in excess) and corresponding BCKA, but very little free TDP
is available to function in decarboxylation of the corresponding BCKA,
which may accumulate. This notion is strengthened by the observation
that rats with more than adequate TDP in the liver, fed high thiamin
diets, had much less total BCKDH activity with an even lower proportion
in the active (dephosphorylated) form, perhaps because the BCKA are
kept in low concentration through oxidation. It was also apparent that
high TDP concentrations in the liver mitochondria alone did not
severely inhibit the BCKDH kinase reaction, as it did with the isolated
complex (Lau et al. 1982
).
It is tempting to speculate that the phosphorylated, inactive form of
BCKDH has a much lower affinity for TDP than does the active form. When
liver TDP is high and the active form is low, there is little BCKDH
activity (<10%) until dephosphorylation is accomplished and TDP is
added. TDP alone restores only ~25% of the BCKDH activity. On the
other hand, when liver TDP is high and the active form is high (>80%
of the total) there is ~50% of the total BCKDH activity in the
absence of added TDP. Rats fed the non-purified reference diet
containing 24% protein (of which 4.5% is BCAA) and 10.84 mg
thiamin/kg diet had a liver concentration of 187 pmol TDP/mg protein,
~50% of total liver BCKDH activity in the absence of added TDP, and
82% of activity before activation with phosphatase. However, rats fed
the chemically-defined diet containing 16% amino acids (of which 2.8%
were BCAA) and 5.5 mg thiamin/kg diet had a liver concentration of 159
pmol TDP/mg protein, 7% of liver BCKDH activity in the absence of
added TDP, and 26% of activity before activation with phosphatase.
This chemically-defined diet may be considered to be a low-protein diet
(Gilliam et al. 1983
, Harris et al. 1985
,
Wohlheuter and Harper 1970
), but it is adequate to
promote maximal growth of weanling rats for 3 wk, indicating that
protein synthesis is not restricted (Table 1)
.
Before thiamin deficiency can increase BCKDH activity in rats, weight
gain must be curtailed, liver thiamin concentration minimized, and
perhaps weight loss must start. Consuming the thiamin-free diet for
5 d dramatically reduces the active form (nonphosphorylated) of
BCKDH and causes a concomitant, almost absolute, requirement for
exogenous TDP; very little TDP (~5%) is bound to the enzyme complex
(Tables 4 and 5)
. However, at some point during the next 21 d, in
rats fed the thiamin-free diet (or 0.275 mg thiamin/kg diet) this
response was reversed to the extent that total BCKDH activity was more
than doubled with >60% of the enzyme complex in the active form
(Table 4)
. It may be that low (inadequate) liver TDP coupled to
adequate BCAA in the diet induces the expression of BCKDH because the
amino acids are not used for protein synthesis, but are used for energy
via transamination to the corresponding ketoacids that subsequently are
oxidized. But if TDP is deficient, the BCKA may induce the synthesis of
BCKDH to oxidize the BCKA. However, more BCKDH will not solve the
problem, whereas more TDP would.
Our experiments with weanling rats indicate a delicate balance between
thiamin deficiency and adequacy. Cycling between the two could help
relieve the symptoms of MSUD by lowering BCAA and BCKA in the blood by
using excess amino acids for energy. Our experiments do not provide
evidence that additional thiamin in the liver of rats leads to greater
BCKDH activity and subsequent lowering of BCAA in the blood plasma. It
may be that increased TDP in the liver of patients with
thiamin-responsive MSUD enhances the decarboxylation activity of the
BCKDH complex and the removal of the BCKA, but not the acyl
transferase, which is the mutated subunit in such patients
(Danner et al. 1985
). Thus, the ketoacid derivatives may
fully saturate the active (dephosphorylated) complexes because the
mutated subunit may exhibit as little as 3% of normal activity. This
saturation could enhance the dephosphorylation of the mutated BCKDH to
the extent that the ketoacid derivatives are reduced to an acceptable
level by the catalytic action brought about by an increase in active
faulty transferase.
Rats fed a chemically-defined diet containing inadequate thiamin (0,
0.275, and 0.55 mg thiamin/kg diet) to promote growth had low liver
-KGDH activity and a low amount of TDP bound to the enzyme complex.
Even at low mitochondrial TDP concentrations (1621 pmol TDP/mg
protein) substantial TDP was bound to the
-KGDH, but over half of
the enzyme activity was exhibited after the addition of TDP to the
assay. In agreement with Pekovich et al. (1996)
,
-KGDH activity is resistant to thiamin depletion, and by inference
the enzyme complex is resistant to mitochondrial proteases even when
the prosthetic group (TDP) is not bound. Thus, TDP binding is not
required to stabilize the
-KGDH against degradative enzymes,
although other coenzymes of the complex may be needed.
When nondeficient levels of thiamin were included in the
chemically-defined diet fed to rats,
-KGDH activity was >90% of
maximal without adding TDP during extraction or assay. This indicates a
high affinity or firm binding of the coenzyme to the protein. In
contrast, at the same dietary thiamin levels, BCKDH activity was low
before adding TDP and dephosphorylating the complex, a result which
illustrates differential binding affinity of TDP to the two similar
enzyme complexes. Certainly, in a condition where mitochondrial TDP is
limited,
-KGDH would be highly favored over BCKDH to bind TDP to the
enzyme complex. Such a hierarchy could be very important for continued
energy generation by a cell or tissue at times of thiamin
insufficiency. This differential affinity of TDP for the two
decarboxylation-dehydrogenation complexes is more sharply illustrated
when comparisons are made after 5 d of acclimation to the
chemically-defined thiamin-free diet. The mitochondrial TDP
concentration was 65 pmol/mg protein (<30% of normal). The BCKDH
activity (57 mU/g wet liver) in the absence of added phosphatase and
TDP was 5% of its possible activity (1129 mU/g wet liver) in the
presence of phosphatase (to dephosphorylate) and TDP, whereas
-KGDH
activity in the absence of added TDP was 90% of its possible activity
(Tables 4 and 5)
.
In summary, the minimal amount of thiamin in a chemically-defined diet
required to promote maximal rates of gain in body weight for weanling
rats for 21 d after 5 d of acclimation to a thiamin-free diet
exceeds 0.55 mg thiamin/kg diet. Dietary thiamin deficiency reduces the
plasma, liver, and liver mitochondrial levels of TDP, and excess
thiamin significantly increases the liver and liver mitochondrial
levels of TDP. Acclimation to the chemically-defined thiamin-free diet
does not curtail growth, but reductions in thiamin compounds in the
plasma and liver are significant. Starvation does not deplete plasma
and liver thiamin. In thiamin deficiency, the tighter binding of TDP by
-KGDH allows retention of
-KGDH activity, perhaps at the expense
of BCKDH activity. Excess dietary thiamin does not induce greater
expression of BCKDH in the liver. In fact, dietary thiamin deficiency
may induce this greater expression of BCKDH. Large alterations in
mitochondrial TDP levels do not affect the stability of the BCKDH
complex nor the activity of its kinase, nor is TDP binding required to
stabilize
-KGDH against degradative enzymes.
| FOOTNOTES |
|---|
1 Presented in abstract form in part at American Society of Biochemistry and Molecular Biology Meetings, Washington, DC [Blair, P. V., Kobayashi, R., Harris, R. A., Baker, D. H., Edwards, H. M., III & Shay, N. F. (1998) Mitochondrial thiamin diphosphate level and the activities of thiamin-dependent enzymes. FASEB J. 12: A1415 (abs)].
Also presented in abstract form in part at American Society of Cell
Biology Meeting, Washington, DC [Blair, P. V., Kobayashi, R.,
Baker, D. H. & Harris, R. A. (1997) Thiamin diphosphate
levels in mitochondria isolated from livers of rats fed diets deficient
in thiamin. Molec. Biol. Cell 8: 445A (abs)]. ![]()
2 Supported in part by awards from the Grace M.
Showalter Trust, PHS DK19259 (rah), International Life Sciences
Institute, North America, and the National Institutes of Health
(AG13586). ![]()
3 The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore be marked "advertisement" in accordance with 18 USC
section 1734 solely to indicate this fact. ![]()
5 Abbreviations used:
-KGDH,
-ketoglutarate
dehydrogenase; ADP, adinosine diphosphate; ATP, adinosine triphosphate;
BCAA, branched-chain amino acid; BCKA, branched-chain
-ketoacid;
BCKDH, branched-chain
-ketoacid dehydrogenase; MSUD, maple syrup
urine disease; NRC, National Research Council; RLM, rat liver
mitochondria; TDP, thiamin diphosphate; TRMA, thiamin-responsive
megaloblastic anemia. ![]()
Manuscript received October 13, 1998. Initial review completed November 4, 1998. Revision accepted December 1, 1998.
| REFERENCES |
|---|
|
|
|---|
1.
Aftring R. P., Black K. P., Buse M. G. Leucine and isoleucine activate skeletal muscle branched-chain
-ketoacid dehydrogenase in vivo. Am. J. Physiol. 1986;250:E599-E604
2. Baker D. H. Problems and pitfalls in animal experiments designed to establish dietary requirements for essential nutrients. J. Nutr. 1986;116:2339-2349
3.
Bettendorff L., Wins P. Mechanism of thiamin transport in neuroblastoma cells inhibition of a high affinity carrier by sodium channel activators and dependence of thiamin uptake on membrane potential and intracellular ATP. J. Biol. Chem. 1994;269:14379-14385
4. Bettendorff L. Thiamine homeostasis in neuroblastoma cells. Neurochem. Int. 1995;26:295-302[Medline]
5. Blair P. V. Induction of mitochondrial contraction and concomitant inhibition of succinate oxidation by magnesium ions. Arch. Biochem. Biophys. 1977;181:550-568[Medline]
6.
Casirola D., Ferrari G., Gastaldi G., Patrini C., Rindi G. Transport of thiamin by brush-border membrane vesicles from rat small intestine. J. Physiol. 1988;398:329-339
7.
Chance B., Williams G. R. Respiratory enzymes in oxidative phosphorylation III: The steady state. J. Biol. Chem. 1955;217:409-427
8. Chuang D. T., Shih G. R. Disorders of branched-chain amino acid and keto acid metabolisms. Scriver C. R. Beaudet A. L. Sly W. S. Valle D. eds. The Metabolic and Molecular Basis of Inherited Diseases 1995;Vol. 1:1239-1277 McGraw-Hill New York, NY.
9. Dancis J., Kutzke J., Rokkones T. Metabolism of white blood cells in maple syrup urine disease. Biochim. Biophys. Acta 1960;43:342-343
10. Danner D. J., Armstrong N., Heffelfinger S. C., Sewell E. T., Priest J. H., Elsas L. J. Absence of branched chain acyltransferase as a cause of maple syrup urine disease. J. Clin. Invest. 1985;75:858-860
11. Dreyfuss P. M. The quantitative histochemical distribution of thiamine in deficient rat brain. J. Neurochem. 1961;8:139-145[Medline]
12. Edwin E. E. An improved procedure for the determination of thiamine. Methods in Enzymology 1979;62:51-54[Medline]
13. Elsas L. J., Danner D. J. The role of thiamin in maple syrup urine disease. Ann. NY Acad. Sci. 1982;378:404-427[Medline]
14. Fernhoff P. M., Lubitz D., Danner D. J., Dembure P. P., Schwartz H. P., Hillman R., Bier D. M., Elsas L. J. Thiamine response in maple syrup urine disease. Pediatr. Res. 1985;19:1011-1016[Medline]
15.
Fisher C. R., Fisher C. W., Chuang D. T., Cox R. P. Occurence of a Tyr393
Asn (Y393N) mutation in the El
gene of the branched-chain
-keto acid dehydrogenase complex in maple syrup urine disease patients from a Menonite population. Am. J. Hum. Genet. 1991;49:429-434[Medline]
16.
Gillim S. E., Paxton R., Cook G. A., Harris R. A. Activity state of the branched-chain
-ketoacid dehydrogenase complex in heart, liver, and kidney of normal, fasted, diabetic, and protein starved rats. Biochem. Biophys. Res. Commun. 1983;111:74-81[Medline]
17.
Gornall G. A., Bardawill C. J., David M. M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 1949;177:751-766
18.
Harris R. A., Powell S. M., Paxton R., Gillim S. E., Nagae H. Physiological covalent regulation of rat liver branched-chain
-ketoacid dehydrogenase. Arch. Biochem. Biophys. 1985;243:542-555[Medline]
19. Herring W. J., McKean M., Dracopoli N., Danner D. J. Branched chain acyltransferase absence due to an Ala-based genomic deletion allele and an exon skipping in a compound heterozygote proband expressing maple syrup urine disease. Biochim. Biophys. Acta 1992;1138:236-242[Medline]
20. Lau K. S., Fatania H. R., Randle P. J. Regulation of the branched-chain 2-oxoacid dehydrogenase kinase reaction. FEBS Lett 1982;144:57-62[Medline]
21.
Menkes J. H., Hurst P. L., Craig J. M. A new syndrome: Progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics 1954;14:462-466
22. Mercer L. P., Dodds S. J., Gustafson J. M. The determination of nutritional requirements: A modeling approach. Nutr. Rept. Int. 1986;34:337-350
23. National Research Council Nutrient Requirements of Laboratory Animals 4th rev. ed. 1995 National Academy of Sciences Washington, D.C.
24. Paxton R., Scislowski P.W.D., Davis E. J., Harris R. A. Role of branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase in 2-oxobutyrate metabolism. Biochem. J. 1986;234:295-303[Medline]
25. Pekovich S. R., Martin P. R., Singleton C. K. Thiamin pyrophosphate-requiring enzymes are altered during pyrothiamin-induced thiamin deficiency in cultured human lymphoblasts. J. Nutr. 1996;126:1791-1798
26. Pekovich S. R., Poggi U., Martin R. R., Singleton C. K. Sensitivity to thiamin deficiency in cultured human cells is dependent on cell type and is enhanced in cells from thiamin-responsive megaloblastic anemia patients. J. Nutr. Biochem. 1998;9:215-222
27.
Rains T. M., Emmert J. L., Baker D. H., Shay N. F. Minimum thiamin requirement of weanling Sprague-Dawley outbred rats. J. Nutr. 1997;127:167-170
28. Rindi G., de Giuseppi L. A new chromotrophic method for the determination of thiamin and its mono-, di-, and tri-phosphates in animal tissues. Biochem. J. 1961;78:602-606
29. Rindi G., Patrini C., Laforcuza U., Mandel H., Berant M., Viana M. B., Poggi V., Zarra A.W.F. Further studies on erythrocyte thiamin transport and phosphorylation in seven patients with thiamin-responsive megaloblastic anemia. J. Inher. Metab. Dis. 1994;17:667-677[Medline]
30. Scriver C. R., MacKenzie S., Chow C. L., Delvin E. Thiamin responsive maple syrup urine disease. Lancet 1971;1:310-312[Medline]
31. Scriver C. R., Clow C. L., George H. So-called thiamin-responsive maple syrup urine disease: 15-year follow-up of the original patient. J. Pediatr. 1985;107:763-765[Medline]
32.
Shimomura Y, Paxton R., Ozawa T., Harris R. A. Purification of branched-chain
-ketoacid dehydrogenase complex from rat liver. Anal. Biochem. 1987;163:74-78[Medline]
33.
Shimomura Y., Suzuki T., Saitoh S., Tasaki Y., Harris R. A., Suzuki M. Activation of branched-chain
-ketoacid dehydrogenase complex by exercise: effect of high-fat diet intake. J. Appl. Physiol. 1990;68:161-165
34. Valerio G., Franzese A., Poggi V., Tenore A. Long-term follow-up of diabetes in two patients with thiamin-responsive megaloblastic anemia syndrome. Diabetes Care 1998;21:38-41[Abstract]
35. Warnock L. G., Prudhomme C. R., Wagner C. The determination of thiamin pyrophosphate in blood and other tissues, and its correlation with erythrocyte transketolase activity. J. Nutr. 1978;108:421-427
36. Westall R. G., Dancis J., Miller S. Maple syrup urine disease. Am. J. Dis. Child. 1957;94:571-572
37.
Wohlheuter R. M., Harper A. E. Co-induction of rat liver branched-chain
-ketoacid dehydrogenase activities. J. Biol. Chem. 1970;245:2391-2401
38.
Yamamoto S., Koyama S., Kawasaki T. Properties of the active thiamin transport system in Ehrlich ascites tumor cells. J. Biochem. (Tokyo) 1981;89:809-816
This article has been cited by other articles:
![]() |
L. Balk, P.-A. Hagerroth, G. Akerman, M. Hanson, U. Tjarnlund, T. Hansson, G. T. Hallgrimsson, Y. Zebuhr, D. Broman, T. Morner, et al. Wild birds of declining European species are dying from a thiamine deficiency syndrome PNAS, July 21, 2009; 106(29): 12001 - 12006. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Chuang, J. L. Chuang, and R. M. Wynn Lessons from Genetic Disorders of Branched-Chain Amino Acid Metabolism J. Nutr., January 1, 2006; 136(1): 243S - 249S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Chuang, R. M. Wynn, C. C. Moss, J.-l. Song, J. Li, N. Awad, H. Mandel, and D. T. Chuang Structural and Biochemical Basis for Novel Mutations in Homozygous Israeli Maple Syrup Urine Disease Patients: A PROPOSED MECHANISM FOR THE THIAMIN-RESPONSIVE PHENOTYPE J. Biol. Chem., April 23, 2004; 279(17): 17792 - 17800. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||